Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Liposome |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002019 |
To evaluate the safety, tolerance and efficacy of three different dosage regimens of Amphotericin B Lipid Complex (ABLC) compared to Fungizone (Amphotericin B) in patients with AIDS and cryptococcal meningitis.
Condition | Intervention |
---|---|
Meningitis, Cryptococcal HIV Infections |
Drug: Amphotericin B, Lipid-based Drug: Amphotericin B |
Study Type: | Interventional |
Study Design: | Treatment, Dose Comparison, Safety Study |
Official Title: | Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patients must have the following:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Prior Medication:
Excluded within 4 weeks of study entry:
United States, California | |
Harbor - UCLA Med Ctr | |
Torrance, California, United States, 90502 | |
United States, Connecticut | |
Dr Thomas Patterson | |
New Haven, Connecticut, United States, 06510 | |
United States, District of Columbia | |
Walter Reed Army Med Ctr | |
Washington, District of Columbia, United States, 203075001 | |
United States, Illinois | |
Rush Presbyterian - Saint Luke's Med Ctr | |
Chicago, Illinois, United States, 60612 | |
United States, Maryland | |
Natl Naval Med Ctr | |
Bethesda, Maryland, United States, 20889 | |
United States, Massachusetts | |
Univ Hosp | |
Boston, Massachusetts, United States, 02118 | |
United States, New Jersey | |
East Orange Veterans Administration Med Ctr | |
East Orange, New Jersey, United States, 07018 | |
Saint Michael's Med Ctr | |
Newark, New Jersey, United States, 07102 | |
United States, New York | |
Mount Sinai Med Ctr / Jack Martin Fund Clinic | |
New York, New York, United States, 10029 | |
Saint Luke's - Roosevelt Hosp Ctr | |
New York, New York, United States, 10025 | |
Dr Dorothy Friedberg | |
New York, New York, United States, 10016 | |
New York Univ Med Ctr | |
New York, New York, United States, 10016 | |
Cornell Univ Med College | |
New York, New York, United States, 10021 | |
Beth Israel Med Ctr / Peter Krueger Clinic | |
New York, New York, United States, 10003 | |
Mount Sinai Med Ctr | |
New York, New York, United States, 10029 | |
United States, Pennsylvania | |
Buckley Braffman Stern Med Associates | |
Philadelphia, Pennsylvania, United States, 19107 | |
United States, Texas | |
Univ TX Galveston Med Branch | |
Galveston, Texas, United States, 77550 | |
Audie L Murphy Veterans Administration Hosp | |
San Antonio, Texas, United States, 78284 | |
United States, Utah | |
Univ of Utah School of Medicine | |
Salt Lake City, Utah, United States, 84132 |
Study ID Numbers: | 051A |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002019 |
Health Authority: | United States: Food and Drug Administration |
Meningitis Liposomes Cryptococcosis |
Acquired Immunodeficiency Syndrome Amphotericin B Chemistry, Pharmaceutical |
Abelcet Amphotericin B Sexually Transmitted Diseases, Viral Meningitis, Fungal Clotrimazole Miconazole Acquired Immunodeficiency Syndrome Tioconazole Central Nervous System Diseases Liposomal amphotericin B |
Immunologic Deficiency Syndromes Meningitis Virus Diseases Mycoses Central Nervous System Infections HIV Infections Sexually Transmitted Diseases Meningitis, Cryptococcal Cryptococcosis Retroviridae Infections |
Anti-Infective Agents RNA Virus Infections Antiprotozoal Agents Slow Virus Diseases Disease Immune System Diseases Nervous System Diseases Infection Pharmacologic Actions Anti-Bacterial Agents |
Antiparasitic Agents Pathologic Processes Antifungal Agents Therapeutic Uses Syndrome Antibiotics, Antifungal Lentivirus Infections Central Nervous System Fungal Infections Amebicides |